Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in CTXR held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | GEODE CAPITAL MANAGEMENT, LLC | 246K | $222K | +93.0% | 2.203% | 0.00% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 168K | $151K | β | 1.501% | 0.00% |
| 3 | VANGUARD FIDUCIARY TRUST CO | 78K | $70K | β | 0.696% | 0.00% |
| 4 | BlackRock, Inc. | 70K | $63K | 0.0% | 0.625% | 0.00% |
| 5 | Asset Advisory Group, Inc. | 59K | $53K | 0.0% | 0.528% | 0.03% |
| 6 | UBS Group AG | 55K | $50K | -28.0% | 0.492% | 0.00% |
| 7 | NORTHERN TRUST CORP | 44K | $40K | 0.0% | 0.394% | 0.00% |
| 8 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 37K | $33K | -54.5% | 0.330% | 0.00% |
| 9 | LPL Financial LLC | 25K | $23K | -0.1% | 0.224% | 0.00% |
| 10 | STATE STREET CORP | 23K | $21K | 0.0% | 0.208% | 0.00% |
| 11 | XTX Topco Ltd | 21K | $19K | -80.1% | 0.191% | 0.00% |
| 12 | Arkadios Wealth Advisors | 20K | $18K | 0.0% | 0.179% | 0.00% |
| 13 | Miller Financial Services LLC | 14K | $13K | β | 0.125% | 0.01% |
| 14 | TWO SIGMA INVESTMENTS, LP | 13K | $12K | -78.4% | 0.118% | 0.00% |
| 15 | IFP Advisors, Inc | 7K | $6K | 0.0% | 0.063% | 0.00% |
| 16 | SBI Securities Co., Ltd. | 7K | $6K | +62.2% | 0.058% | 0.00% |
| 17 | CITIGROUP INC | 5K | $5K | +520.2% | 0.047% | 0.00% |
| 18 | Quent Capital, LLC | 4K | $4K | +361.1% | 0.038% | 0.00% |
| 19 | CHELSEA COUNSEL CO | 5K | $4K | 0.0% | 0.041% | 0.00% |
| 20 | Tower Research Capital LLC (TRC) | 3K | $3K | -0.8% | 0.025% | 0.00% |
| 21 | ADVISOR GROUP HOLDINGS, INC. | 3K | $2K | +83.9% | 0.025% | 0.00% |
| 22 | CURIO WEALTH, LLC | 2K | $2K | 0.0% | 0.018% | 0.00% |
| 23 | Vanguard Global Advisers, LLC | 2K | $2K | β | 0.016% | 0.00% |
| 24 | MORGAN STANLEY | 1K | $1K | -32.9% | 0.012% | 0.00% |
| 25 | Ameritas Advisory Services, LLC | 1K | $900 | β | 0.009% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in CTXR β a direct measure of their conviction.
Filings activity in CTXR during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 35 | 10% | 13.62% | 9.42 pp | $1M | 41% |
| Q4 2025 | 39 | +18% | 23.04% | +10.28 pp | $1M | +81% |
| Q3 2025 | 33 | +6.5% | 12.76% | 7.77 pp | $1M | 38% |
| Q2 2025 | 31 | +6.9% | 20.53% | +4.85 pp | $1M | +31% |
| Q1 2025 | 29 | 6.5% | 15.68% | 24.73 pp | $1M | 61% |
| Q4 2024 | 31 | 47% | 40.41% | 153.99 pp | $2M | 79% |
| Q3 2024 | 58 | 17% | 194.40% | 5.59 pp | $12M | 33% |
| Q2 2024 | 70 | β | 199.99% | β | $18M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying CTXR stock.
Based on Q1 2026 13F filings, institutional ownership of Citius Pharmaceuticals, Inc. stands at 13.6%, held across 35 reporting institutions.
GEODE CAPITAL MANAGEMENT, LLC is the largest reported institutional holder of CTXR, with approximately 246,158 shares worth $0.00B as of Q1 2026.
Yes β 2 widely-followed marquee investors appear among the top 25 institutional holders of CTXR, including SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA INVESTMENTS, LP.
Our composite Smart Money Score for CTXR is 38 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
9 institutions opened new positions in CTXR during Q1 2026, while 13 fully exited. 20 added to existing positions and 5 trimmed.
CTXR institutional ownership fell by 9.42 percentage points quarter-over-quarter, with a net change of -4 holders.
The top 10 institutions account for 88.1% of all reported 13F value in CTXR, and the top 25 account for 99.9%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Citius Pharmaceuticals, Inc. (CTXR) Institutional Ownership